KUALA LUMPUR (June 2): Germany headquartered medical technology company B. Braun is expanding its portfolio of testing capabilities for healthcare solutions in Penang.
In a joint statement, Malaysian Investment Development Authority (MIDA) and B. Braun said the testing capabilities related to intravenous access, surgical technologies, intravenous systems, central venous puncture and pain control.
They said prior to the expansion, the Global Test Centre in Penang had only supported 200,000 scientific measurements per annum for medical devices related to intravenous access and drug delivery systems.
Due to the proven competencies, strong product knowledge and efficiency displayed by the local team of Malaysian engineers, the volume of product testing has been tripled to more than 600,000 scientific measurements per annum, they said.
The Global Test Centre conducts design validation, discovery and shelf life testing, as well as failure analysis; and features state-of-the art test equipment and a fully integrated data management system, which is crucial to ensure the safety and efficacy of medical devices, used in the treatment of patients around the world.
All products are tested to ensure adherence to the stringent requirements of the European Medical Device Regulation (EU MDR), United States Food & Drug Administration (US FDA) and other recognised regulatory authorities.
MIDA chief executive officer Datuk Azman Mahmud said the Malaysian medical device industry has showed great promise in creating high quality employment, reinforcing the domestic supply chain ecosystem, and generating greater export value.
“We have a strong presence of established supporting industries conforming to world-class standards that support the medical devices industry in the country.
“The nation's legacy expertise in precision electronics has also provided our workforce the requisite skills in quality management and precision. We trust that these qualities draw world leaders in healthcare including B. Braun to continuously embrace the abundant business opportunities in Malaysia today,” he said.
Meanwhile, B. Braun Asia Pacific president Lam Chee Hong said that staffed by a proven team of highly competent Malaysians, the Global Test Centre in Penang will further ensure that patients everywhere will continue to receive medical devices of the highest global standards.
#dudukrumahdiamdiam and get the news at theedgemarkets.com.